DNAprint Genomics (DNAG)

[geob]

TWST: Tell us about the company's management and its goals for the
future.


Mr. Gabriel: We've all been working at this for some time. I've been in
the pharmaceutical business for 20 years.

Dr. Hector Gomez, our Chairman and Chief Medical Officer, has been in it
all of his life. He has 11 drugs under his belt; I have four or five and
probably have been involved with 60 or 70 ' from discovery all the way
to approval ' over the course of my career. There are three or four
drugs on the market now that have gone through my previous company's
hands. We're dedicated individuals, and I thank our shareholders for
believing in our company. And that, quite honestly, is why we're looking
for acquisitions. We want to build our revenue, and we either build our
revenue through sales, selling a new technology into a market, which is
hard, or we acquire it ' and we're aggressively looking at both because
the goal is to boost shareholder value. I myself am a shareholder.

GEO